GSK Q3 Sales Rise 4% as Core EPS Beats Consensus by 4.2 Pence

Photo: TokenPost
Specialty Medicines sales grew 15% at constant exchange rates, and GSK reaffirmed its 2026 outlook.
Source: TokenPost
An independent desk covering Stake, the US casino market and crypto.

Photo: TokenPost
Specialty Medicines sales grew 15% at constant exchange rates, and GSK reaffirmed its 2026 outlook.
Source: TokenPost